Zimmer Biomet Holdings, Inc. (ZBH)

119,43 +0,10 (+0,08%) Alla chiusura: 04:00PM EDT

Zimmer Biomet Holdings, Inc.

345 East Main Street
Warsaw, IN 46580
United States
574 373 3333
https://www.zimmerbiomet.com

Settore/i: Healthcare
Settore: Medical Devices
Impiegati a tempo pieno: 18.000

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Mr. Ivan Tornos	COO, President, CEO & Director	2,72M	N/D	1975
Mr. Suketu P. Upadhyay	CFO and Executive VP of Finance, Operations & Supply Chain	2,01M	N/D	1969
Mr. Chad F. Phipps	Senior VP, General Counsel & Secretary	1,32M	1,23M	1972
Mr. Sang Yi	President of Asia Pacific	1,38M	N/D	1962
Mr. Wilfred van Zuilen	Group President of Europe, Middle East & Africa	1,47M	N/D	1970
Mr. Paul A. Stellato	VP, Controller & Chief Accounting Officer	N/D	N/D	1975
Dr. Nitin Goyal M.D.	Chief Science, Technology & Innovation Officer	N/D	N/D	N/D
Mr. Zeeshan Tariq	Senior VP & Chief Information Officer	N/D	N/D	N/D
Ms. Keri P. Mattox	SVP and Chief Communications & Administration Officer	N/D	N/D	N/D
Mr. Zachary Ross Weiner CPA	Director of Investor Relations	N/D	N/D	N/D

Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers robotic, surgical, and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Governance aziendale

L'ISS Governance QualityScore di Zimmer Biomet Holdings, Inc. al 1 aprile 2024 è 6. I criteri di valutazione fondamentali sono revisione: 2; Consiglio di Amministrazione: 3; diritti degli azionisti: 4; retribuzione: 10.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.